University of California, San Diego: Dermatology Clinical Trials Unit
Welcome,         Profile    Billing    Logout  
 2 Trials 
10 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Gallo, Richard
NCT06504160: Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)

Not yet recruiting
2
86
US
ShA9 Topical Gel, Hydrocortisone Ointment, Clobetasol Ointment, Fluocinonide Ointment, Placebo (Vehicle) Topical Gel
National Institute of Allergy and Infectious Diseases (NIAID), Atopic Dermatitis Research Network (ADRN), Rho Federal Systems Division, Inc., PPD, Thermo Fisher Scientific Inc.
Atopic Dermatitis
06/26
07/26
TIME-1, NCT05177328: Targeted Investigation of Microbiome Elimination

Terminated
1
21
US
S. hominis A 9 Product, ShA9, Placebo, Placebo for S. hominis A 9 Product
National Institute of Allergy and Infectious Diseases (NIAID), Atopic Dermatitis Research Network
Atopic Dermatitis
08/23
10/23
Hata, Tissa
LEADS, NCT05436535: Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis

Recruiting
4
600
US
Dupilumab, Dupixent, Vanicream- Dupilumab-naïve, Triamcinolone Acetonide, Hydrocortisone, Vanicream- Active, Vanicream- Experienced Dupilumab
National Institute of Allergy and Infectious Diseases (NIAID)
Atopic Dermatitis
05/25
10/25
NCT06504160: Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)

Not yet recruiting
2
86
US
ShA9 Topical Gel, Hydrocortisone Ointment, Clobetasol Ointment, Fluocinonide Ointment, Placebo (Vehicle) Topical Gel
National Institute of Allergy and Infectious Diseases (NIAID), Atopic Dermatitis Research Network (ADRN), Rho Federal Systems Division, Inc., PPD, Thermo Fisher Scientific Inc.
Atopic Dermatitis
06/26
07/26
TIME-1, NCT05177328: Targeted Investigation of Microbiome Elimination

Terminated
1
21
US
S. hominis A 9 Product, ShA9, Placebo, Placebo for S. hominis A 9 Product
National Institute of Allergy and Infectious Diseases (NIAID), Atopic Dermatitis Research Network
Atopic Dermatitis
08/23
10/23
Seibold, Max
LEADS, NCT05436535: Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis

Recruiting
4
600
US
Dupilumab, Dupixent, Vanicream- Dupilumab-naïve, Triamcinolone Acetonide, Hydrocortisone, Vanicream- Active, Vanicream- Experienced Dupilumab
National Institute of Allergy and Infectious Diseases (NIAID)
Atopic Dermatitis
05/25
10/25
TIP, NCT04628442: Tissue Immune Interaction in Nasal Polyposis

Recruiting
N/A
100
US
Sinonasal Debridement Procedure, Nasal Polyp Removal, Biopsy
University of California, San Francisco, National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)
Chronic Rhinosinusitis (Diagnosis), Chronic Rhinosinusitis With Nasal Polyps, Asthma
03/25
03/25
Osuoji, Olive
LEADS, NCT05436535: Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis

Recruiting
4
600
US
Dupilumab, Dupixent, Vanicream- Dupilumab-naïve, Triamcinolone Acetonide, Hydrocortisone, Vanicream- Active, Vanicream- Experienced Dupilumab
National Institute of Allergy and Infectious Diseases (NIAID)
Atopic Dermatitis
05/25
10/25
Fernandez-Desoto, Alexandra
LEADS, NCT05436535: Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis

Recruiting
4
600
US
Dupilumab, Dupixent, Vanicream- Dupilumab-naïve, Triamcinolone Acetonide, Hydrocortisone, Vanicream- Active, Vanicream- Experienced Dupilumab
National Institute of Allergy and Infectious Diseases (NIAID)
Atopic Dermatitis
05/25
10/25
NCT06504160: Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)

Not yet recruiting
2
86
US
ShA9 Topical Gel, Hydrocortisone Ointment, Clobetasol Ointment, Fluocinonide Ointment, Placebo (Vehicle) Topical Gel
National Institute of Allergy and Infectious Diseases (NIAID), Atopic Dermatitis Research Network (ADRN), Rho Federal Systems Division, Inc., PPD, Thermo Fisher Scientific Inc.
Atopic Dermatitis
06/26
07/26

Download Options